Medline Inc. MDLN
MDLN among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
MDLN and 9 peers, year by year
The 9 Health care companies closest to MDLN in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| MDLN Medline Inc. | FY2025 | $28.4B | +11.5% | 26.4% | 7.8% | 4.1% | 4.6% | 10.8% | 1.17 |
| GILD Gilead Sciences | FY2025 | $29.4B | +2.4% | - | 34.0% | 28.9% | 32.1% | 37.5% | 1.10 |
| SYK Stryker Corporation | FY2025 | $25.1B | +11.2% | 64.0% | 19.5% | 12.9% | 17.1% | 14.5% | 0.66 |
| DHR Danaher Corporation | FY2025 | $24.6B | +2.9% | 59.1% | 19.1% | 14.7% | 21.4% | 6.9% | 0.35 |
| MDT Medtronic | FY2026 | $36.4B | +8.4% | - | 17.8% | 13.2% | 14.9% | 9.7% | 0.57 |
| BDX Becton Dickinson | FY2025 | $21.8B | +8.2% | - | 11.8% | 7.7% | 12.2% | 6.6% | 0.76 |
| AMGN Amgen | FY2025 | $36.8B | +10.0% | - | 24.7% | 21.0% | 22.0% | 89.1% | 6.31 |
| THC Tenet Healthcare Corp | FY2025 | $21.3B | +3.1% | - | 16.5% | 6.6% | 11.9% | 33.3% | 3.12 |
| GEHC GE HealthCare | FY2025 | $20.6B | +4.8% | 40.0% | 13.4% | 10.1% | 7.3% | 20.1% | 1.01 |
| BSX Boston Scientific | FY2025 | $20.1B | +19.9% | 69.0% | 18.0% | 14.4% | 18.2% | 12.0% | 0.47 |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2023 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2023 to FY2025
Revenue as reported in the 10-K.
| Company | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| MDLN Dec | $23.2B | $25.5B | $28.4B |
| GILD Dec | $27.1B | $28.8B | $29.4B |
| SYK Dec | $20.5B | $22.6B | $25.1B |
| DHR Dec | $23.9B | $23.9B | $24.6B |
| MDT Apr | $31.2B | $32.4B | $33.5B |
| BDX Sep | $19.4B | $20.2B | $21.8B |
| AMGN Dec | $28.2B | $33.4B | $36.8B |
| THC Dec | $20.6B | $20.7B | $21.3B |
| GEHC Dec | $19.6B | $19.7B | $20.6B |
| BSX Dec | $14.2B | $16.7B | $20.1B |
| Peer median | $20.6B | $22.6B | $24.6B |
Sales growth, FY2023 to FY2025
Revenue against the fiscal year before.
| Company | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| MDLN Dec | - | +9.8% | +11.5% |
| GILD Dec | −0.6% | +6.0% | +2.4% |
| SYK Dec | +11.1% | +10.2% | +11.2% |
| DHR Dec | −10.3% | −0.1% | +2.9% |
| MDT Apr | −1.4% | +3.6% | +3.6% |
| BDX Sep | +2.7% | +4.2% | +8.2% |
| AMGN Dec | +7.1% | +18.6% | +10.0% |
| THC Dec | +7.2% | +0.5% | +3.1% |
| GEHC Dec | +6.6% | +0.6% | +4.8% |
| BSX Dec | +12.3% | +17.6% | +19.9% |
| Peer median | +6.6% | +4.2% | +4.8% |
Gross margin, FY2023 to FY2025
Gross profit / revenue.
Operating margin, FY2023 to FY2025
Operating income / revenue.
Net margin, FY2023 to FY2025
Net income / revenue.
Free cash flow, FY2023 to FY2025
Cash from operations minus capital spending.
FCF margin, FY2023 to FY2025
Free cash flow / revenue.
Return on equity, FY2023 to FY2025
Net income / shareholders' equity at the year end.
Debt / equity, FY2023 to FY2025
Total debt / shareholders' equity at the year end.
EPS (diluted), FY2023 to FY2025
Diluted earnings per share, on today's share count after splits.
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out MDLN and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: MDLN's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDLN/export.csv") into a cell.